Upcoming Webinar
The Practice + Patient Impact of Step Edit Policies
Date: June 3, 2026 | 2:00 PM
Login to Watch this Webinar
To watch the live webinar, login to your account or register to gain access to our exclusive content.
Step edit policies are affecting more than treatment access — they are influencing workflows, care coordination, and the patient experience across oncology practice.
In this session, Melissa Shimanek, PharmD, BCACP (Rocky Mountain Cancer Centers) will explore the broader practice and patient impact of step edit policies and what these evolving requirements may mean for the future of Bruton’s tyrosine kinase inhibitor (BTKi) therapy access.
What you’ll learn
- The administrative impact step edits can create across prior authorizations, appeals, and care coordination
- How payer-driven sequencing requirements may affect treatment planning and clinical autonomy
- Patient concerns that can arise when coverage requirements influence therapy changes
- The potential impact of payer alignment trends and federal pricing reforms on future BTKi access
For additional information or login assistance, reach out to NCODA’s Jonathan Rivera.
